Oncolytics Biotech Inc
TSX:ONC
Oncolytics Biotech Inc
Revenue
Oncolytics Biotech Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Oncolytics Biotech Inc
TSX:ONC
|
Revenue
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Revenue
$76m
|
CAGR 3-Years
25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Revenue
$51.1m
|
CAGR 3-Years
700%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Revenue
$2.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Revenue
$191.4m
|
CAGR 3-Years
55%
|
CAGR 5-Years
233%
|
CAGR 10-Years
70%
|
|
Spectral Medical Inc
TSX:EDT
|
Revenue
CA$1.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-5%
|
See Also
What is Oncolytics Biotech Inc's Revenue?
Revenue
0
CAD
Based on the financial report for Dec 31, 2023, Oncolytics Biotech Inc's Revenue amounts to 0 CAD.